NEWS

NIPE (Newborn Infant Parasympathetic Evaluation) technology was present in the Perinatal Society of Sri Lanka Congress in Colombo on August 17th and 18th. MDoloris Medical System was represented by our business partner Meditechnology, which their primary focus was on the introduction of novel therapies in the treatment of hypothermia in the NICU.      

Adhering to the clinical research protocols will always acquire the right results. In this Study, Upton has shown that if ANI is maintained between 50 and 70, the pain scores of your patients will be dramatically reduced. This decreases postoperative pain levels, as well as, the side effects related to opioid overdosing. On the other… View Article

A new diagnostic accuracy STUDY that demonstrates how the use of NIPE (Newborn Infant Parasympathetic Evaluation) can be a continuous and effective measurement to assess procedural distress compared to the CBS (Comfort Behavior Scale) in sedated intubated children under 3 years old.      

Read more here..

ANI Technology was present at the KSA (Korean Society of Anesthesiologists) Congress last July 24th and 25th, in Busan, Korea. MDoloris Medical Systems was represented by our business partner Eujin Med-Electronics Co Ltd. We are happy to exhibit our state of the art ANI technology in such a big event and continuously aim to be… View Article

Join us on Tuesday, July 14th at 9:50 AM (CET) for our webinar to learn about all the benefits of NIPE (Newborn Infant Parasympathetic Evaluation) in NICU; Homeostatic Balance and Benefits Over Standard Practice. Register HERE  

New pilot study that demonstrates how  NIPE (Newborn Infant Parasympathetic Evaluation) can detect nociception and analgesics administration more accurately than HR in patients from 0 to 2 years old. Read the study HERE    

Read THIS new insightful article by Dr. Mario Marczuk demonstrating the usage of PTA (Parasympathetic Tone Activity) to objectively measure the impact of Feliway on the comfort of  cats          

Another informative publication, which demonstrates how ANI (Analgesia Nociception Index) can reduce the amount of remifentanil during Colonoscopies compared to standard practice, improving the safety of the procedure. Objective monitoring methods are suggested to be used to avoid possible unwanted effects of anesthesia medication and to apply sufficient doses tailored for individual patients. Opioid consumption… View Article

We had the pleasure of listening to innovative, new ideas in our recent Webinar about the relationship between Heart Rate Variability and COVID19 disease from Prof. Jan Paul Mulier, the sedation approach and how ANI may help in COVID19 patients by Dr. Rafael Badenes and the prognosis value of ANI in these patients by Dr…. View Article